393 related articles for article (PubMed ID: 16204618)
1. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
2. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
3. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis.
Rogers AM; Thilenius AR; Russell JH
J Immunol; 1997 Oct; 159(7):3140-7. PubMed ID: 9317111
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.
Wang JK; Zhu B; Ju ST; Tschopp J; Marshak-Rothstein A
Cell Immunol; 1997 Aug; 179(2):153-64. PubMed ID: 9268499
[TBL] [Abstract][Full Text] [Related]
6. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.
Hadj-Slimane R; Chelbi-Alix MK; Tovey MG; Bobé P
J Interferon Cytokine Res; 2004 Dec; 24(12):717-28. PubMed ID: 15684739
[TBL] [Abstract][Full Text] [Related]
7. T cell dependent and independent antitumor immunity generated by the expression of Fas ligand on mouse lung carcinoma cells.
Tada Y; O-Wang J; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
Int J Mol Med; 2002 Mar; 9(3):281-5. PubMed ID: 11836634
[TBL] [Abstract][Full Text] [Related]
8. Evidence of alternative or concomitant use of perforin- and Fas-dependent pathways in a T cell-mediated negative regulation of Ig production.
Majlessi L; Bordenave G
J Immunol; 1999 Apr; 162(8):4391-8. PubMed ID: 10201974
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory arthropathy in MRL hematopoietic chimeras undergoing Fas mediated graft-versus-host syndrome.
Bonardelle D; Bobé P; Reynès M; Amouroux J; Tricottet V; Godeau F; Kiger N
J Rheumatol; 2001 May; 28(5):956-61. PubMed ID: 11361222
[TBL] [Abstract][Full Text] [Related]
10. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.
Bobé P; Bonardelle D; Reynès M; Godeau F; Mahiou J; Joulin V; Kiger N
J Immunol; 1997 Nov; 159(9):4197-204. PubMed ID: 9379013
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice.
Booker JK; Reap EA; Cohen PL
J Immunol; 1998 Nov; 161(9):4536-41. PubMed ID: 9794379
[TBL] [Abstract][Full Text] [Related]
12. Fas receptor signaling is requisite for B cell differentiation.
Pasqualetto V; Vasseur F; Zavala F; Schneider E; Ezine S
J Leukoc Biol; 2005 Nov; 78(5):1106-17. PubMed ID: 16266974
[TBL] [Abstract][Full Text] [Related]
13. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
[TBL] [Abstract][Full Text] [Related]
14. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
15. In vivo activation of invariant V alpha 14 natural killer T cells by alpha-galactosylceramide sequentially induces Fas-dependent and -independent cytotoxicity.
Lisbonne M; Hachem P; Tonanny MB; Fourneau JM; Sidobre S; Kronenberg M; Van Endert P; Dy M; Schneider E; Leite-de-Moraes MC
Eur J Immunol; 2004 May; 34(5):1381-8. PubMed ID: 15114671
[TBL] [Abstract][Full Text] [Related]
16. Fas system-mediated apoptosis suppresses lymphopoiesis.
Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects on the inhibition of human CD8+ cytotoxic T lymphocytes-mediated killing against xenograft cells by coexpression of membrane-bound Human FasL and decoy Fas antigen.
Tanemura M; Kawamoto K; Ito T; Uchikoshi F; Shimada K; Nishida T; Matsuda H
Transplant Proc; 2005 Dec; 37(10):4607-9. PubMed ID: 16387181
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
Rich RF; Cook WJ; Green WR
Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
[TBL] [Abstract][Full Text] [Related]
19. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
20. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]